Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu’s arteritis

Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is reg...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 27; no. 1; pp. 11 - 15
Main Authors Guo, Shuning, Li, Jiehan, Pang, Shurui, Li, Jing, Tian, Xinping
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.01.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
AbstractList Abstract Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu’s arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Methods Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. Results The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Conclusion Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK. Methods Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients. Results The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort. Conclusion Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury. Keywords: Takayasu's arteritis, Vascular remodeling, Vascular smooth muscle cells, Exosome, miRNA
Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.BACKGROUNDAdvances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.METHODSSerum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.RESULTSThe coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.CONCLUSIONOur study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
ArticleNumber 11
Audience Academic
Author Li, Jing
Guo, Shuning
Pang, Shurui
Tian, Xinping
Li, Jiehan
Author_xml – sequence: 1
  givenname: Shuning
  surname: Guo
  fullname: Guo, Shuning
– sequence: 2
  givenname: Jiehan
  surname: Li
  fullname: Li, Jiehan
– sequence: 3
  givenname: Shurui
  surname: Pang
  fullname: Pang, Shurui
– sequence: 4
  givenname: Jing
  surname: Li
  fullname: Li, Jing
– sequence: 5
  givenname: Xinping
  surname: Tian
  fullname: Tian, Xinping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39833857$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9u1DAQxi1URNuFF-CAInHhkuL_cU6oqgpUqoSEytmaOJPFJYkXO1t1b7wGr9cnqXfToi5CyIozsb_5aSbzHZODMYxIyGtGTxgz-n1iglaqpDw_QuaIPSNHTFam1ELzgyfxITlO6ZpSzmsuX5BDURshjKqOiD-_DSkMWAz-a8nqGkq1KobQrnuYsC1uILkcxiJiPsTej8sCxrbwY9fDMMAU4mb74fspwuTDWISuuIIfsIG0vvv1OxUQJ4x-8ukled5Bn_DVw3tBvn08vzr7XF5--XRxdnpZOiX0VFYMQLWUa9cY1QhoDJVIu65RnTSUNlTUFLQE0ymsTFsJpo0UDGTLHTBaiQW5mLltgGu7in6AuLEBvN0dhLi0uSbverTIKiUUZ6rhVMo6g7Q04HSNgmrsZGZ9mFmrdTNg63DMbfZ70P2b0X-3y3BjGasyUPJMePdAiOHnGtNkB58c9j2MGNbJCqYqpaTU28LfztIl5NryTw0Z6bZye2q4zBPe7gty8g9VXi0O3mWD5FngfsKbpz38Kf7RA1lgZoGLIaWInXV-2g0zk31vGbVbu9nZbjbbze7sZllO5X-lPtL_k3QP-w7XMA
CitedBy_id crossref_primary_10_3390_ijms26072881
Cites_doi 10.1161/CIRCULATIONAHA.120.049922
10.1371/journal.pone.0206239
10.3390/diagnostics12102565
10.1007/s11926-019-0848-3
10.1111/eci.13697
10.1016/j.ejrad.2013.06.019
10.1016/j.ijcard.2017.12.066
10.3390/ijms22147284
10.1096/fj.201701558R
10.1093/nar/gkaa1039
10.3390/jcdd8120187
10.1253/circj.CJ-12-0131
10.1002/jcb.28631
10.1002/adma.201802896
10.1093/nar/gkac519
10.1016/j.gene.2017.03.032
10.1097/MD.0000000000007558
10.1002/acr.24117
10.1002/art.1780330811
10.1093/rheumatology/kex333
10.7150/thno.46143
10.1007/s00018-023-04793-w
10.1016/j.amjms.2017.08.018
10.1016/j.gene.2019.144193
10.1016/j.bbrc.2018.02.051
10.1161/01.CIR.0000089089.42153.5E
10.1161/CIRCULATIONAHA.106.619056
10.1161/01.CIR.0000090689.69973.B1
10.1161/ATVBAHA.119.312787
10.1055/s-0029-1225668
10.1016/j.cellsig.2018.08.019
10.1038/s41572-021-00327-5
10.1186/s12964-022-00949-6
10.3389/fimmu.2021.811485
10.1111/jcmm.14060
10.1016/j.ijcard.2015.12.006
10.1093/nar/gkt1248
10.1016/S0140-6736(23)01736-1
10.7326/0003-4819-120-11-199406010-00004
10.1016/j.cjca.2016.02.070
10.3389/fimmu.2022.859502
10.2478/rir-2023-0002
10.1096/fj.201901548R
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/s13075-025-03475-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 15
ExternalDocumentID oai_doaj_org_article_e17535215b20449684648ac69e306ef4
PMC11744942
A824347824
39833857
10_1186_s13075_025_03475_1
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National High Level Hospital Clinical Research Funding
  grantid: 2022-PUMCH-A-006
– fundername: National High Level Hospital Clinical Research Funding
  grantid: 2022-PUMCH-B-013
– fundername: CAMS Innovation Fund for Medical Sciences
  grantid: 2021-I2M-1-005
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c536t-71aa5d026cb85b3ab804e0ffb5f4800b0390a64a8f5e78d73168431a4d2ca1073
IEDL.DBID DOA
ISSN 1478-6362
1478-6354
IngestDate Wed Aug 27 01:26:06 EDT 2025
Thu Aug 21 18:40:16 EDT 2025
Mon Jul 21 11:54:02 EDT 2025
Tue Jun 17 22:00:03 EDT 2025
Tue Jun 10 20:55:08 EDT 2025
Mon Jul 21 05:33:57 EDT 2025
Tue Jul 01 04:01:04 EDT 2025
Thu Apr 24 23:08:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Vascular remodeling
miRNA
Takayasu’s arteritis
Exosome
Vascular smooth muscle cells
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-71aa5d026cb85b3ab804e0ffb5f4800b0390a64a8f5e78d73168431a4d2ca1073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/e17535215b20449684648ac69e306ef4
PMID 39833857
PQID 3157554467
PQPubID 23479
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_e17535215b20449684648ac69e306ef4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11744942
proquest_miscellaneous_3157554467
gale_infotracmisc_A824347824
gale_infotracacademiconefile_A824347824
pubmed_primary_39833857
crossref_citationtrail_10_1186_s13075_025_03475_1
crossref_primary_10_1186_s13075_025_03475_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-20
PublicationDateYYYYMMDD 2025-01-20
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-20
  day: 20
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 3475_CR40
3475_CR20
3475_CR42
3475_CR41
3475_CR22
3475_CR44
3475_CR21
3475_CR43
3475_CR24
3475_CR23
3475_CR26
3475_CR25
3475_CR28
3475_CR27
3475_CR29
3475_CR31
3475_CR30
3475_CR11
3475_CR33
3475_CR10
3475_CR32
3475_CR13
3475_CR35
3475_CR12
3475_CR34
3475_CR2
3475_CR15
3475_CR37
3475_CR1
3475_CR14
3475_CR36
3475_CR4
3475_CR17
3475_CR39
3475_CR3
3475_CR16
3475_CR38
3475_CR6
3475_CR19
3475_CR5
3475_CR18
3475_CR8
3475_CR7
3475_CR9
References_xml – ident: 3475_CR8
  doi: 10.1161/CIRCULATIONAHA.120.049922
– ident: 3475_CR17
  doi: 10.1371/journal.pone.0206239
– ident: 3475_CR40
  doi: 10.3390/diagnostics12102565
– ident: 3475_CR1
  doi: 10.1007/s11926-019-0848-3
– ident: 3475_CR20
  doi: 10.1111/eci.13697
– ident: 3475_CR36
  doi: 10.1016/j.ejrad.2013.06.019
– ident: 3475_CR42
  doi: 10.1016/j.ijcard.2017.12.066
– ident: 3475_CR3
  doi: 10.3390/ijms22147284
– ident: 3475_CR27
  doi: 10.1096/fj.201701558R
– ident: 3475_CR18
  doi: 10.1093/nar/gkaa1039
– ident: 3475_CR41
  doi: 10.3390/jcdd8120187
– ident: 3475_CR44
  doi: 10.1253/circj.CJ-12-0131
– ident: 3475_CR30
  doi: 10.1002/jcb.28631
– ident: 3475_CR12
  doi: 10.1002/adma.201802896
– ident: 3475_CR21
  doi: 10.1093/nar/gkac519
– ident: 3475_CR28
  doi: 10.1016/j.gene.2017.03.032
– ident: 3475_CR38
  doi: 10.1097/MD.0000000000007558
– ident: 3475_CR2
  doi: 10.1002/acr.24117
– ident: 3475_CR13
  doi: 10.1002/art.1780330811
– ident: 3475_CR23
  doi: 10.1093/rheumatology/kex333
– ident: 3475_CR24
  doi: 10.7150/thno.46143
– ident: 3475_CR15
  doi: 10.1007/s00018-023-04793-w
– ident: 3475_CR32
  doi: 10.1016/j.amjms.2017.08.018
– ident: 3475_CR31
  doi: 10.1016/j.gene.2019.144193
– ident: 3475_CR29
  doi: 10.1016/j.bbrc.2018.02.051
– ident: 3475_CR35
  doi: 10.1161/01.CIR.0000089089.42153.5E
– ident: 3475_CR34
  doi: 10.1161/CIRCULATIONAHA.106.619056
– ident: 3475_CR43
  doi: 10.1161/01.CIR.0000090689.69973.B1
– ident: 3475_CR9
  doi: 10.1161/ATVBAHA.119.312787
– ident: 3475_CR37
  doi: 10.1055/s-0029-1225668
– ident: 3475_CR7
  doi: 10.1016/j.cellsig.2018.08.019
– ident: 3475_CR10
  doi: 10.1038/s41572-021-00327-5
– ident: 3475_CR11
  doi: 10.1186/s12964-022-00949-6
– ident: 3475_CR4
  doi: 10.3389/fimmu.2021.811485
– ident: 3475_CR25
  doi: 10.1111/jcmm.14060
– ident: 3475_CR39
  doi: 10.1016/j.ijcard.2015.12.006
– ident: 3475_CR19
  doi: 10.1093/nar/gkt1248
– ident: 3475_CR22
  doi: 10.1016/S0140-6736(23)01736-1
– ident: 3475_CR14
  doi: 10.7326/0003-4819-120-11-199406010-00004
– ident: 3475_CR33
  doi: 10.1016/j.cjca.2016.02.070
– ident: 3475_CR5
  doi: 10.3389/fimmu.2022.859502
– ident: 3475_CR6
  doi: 10.2478/rir-2023-0002
– ident: 3475_CR16
– ident: 3475_CR26
  doi: 10.1096/fj.201901548R
SSID ssj0022924
Score 2.4581647
Snippet Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing...
Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the...
Abstract Background Advances in treatment have swiftly alleviated systemic inflammation of Takayasu’s arteritis (TAK), while subclinical vascular inflammation...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 11
SubjectTerms Adult
Analysis
Apoptosis
Care and treatment
Cell Movement
Cell Proliferation
Cells, Cultured
Coculture Techniques
Diagnosis
Exosome
Exosomes - genetics
Exosomes - metabolism
Female
Genetic aspects
Genetic markers
Humans
Inflammation - genetics
Inflammation - metabolism
Inflammation - pathology
Male
MicroRNA
MicroRNAs - genetics
MicroRNAs - metabolism
Middle Aged
miRNA
Muscle, Smooth, Vascular - metabolism
Muscle, Smooth, Vascular - pathology
Myocytes, Smooth Muscle - metabolism
Myocytes, Smooth Muscle - pathology
Phenotype
Takayasu Arteritis - genetics
Takayasu Arteritis - metabolism
Takayasu Arteritis - pathology
Takayasu's arteritis
Vascular remodeling
Vascular Remodeling - genetics
Vascular Remodeling - physiology
Vascular smooth muscle cells
Title Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu’s arteritis
URI https://www.ncbi.nlm.nih.gov/pubmed/39833857
https://www.proquest.com/docview/3157554467
https://pubmed.ncbi.nlm.nih.gov/PMC11744942
https://doaj.org/article/e17535215b20449684648ac69e306ef4
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbtFkovpe96uw0qFHooZiPrYfmYLVmWwi5l2UBuQk8aurGXdQLtbf9G_15_SUeyHWIK7aWHmCSSsayZ0TeDRt8g9J67UpuiBM_NGZszYUNupBA5K4MnmmrAiHjA-fxCnC3Y5yVf7pX6ijlhHT1wN3HHPlJJAsZwU0wZqwTgJZPaisqDs-tDYgIFzBuCqT7UKiCsGI7ISHHcwkpdxpPI8KEMvpERDCW2_j_X5D1QGidM7iHQ6RP0uHcd8awb8lN0z9fP0MPzfnP8OVrNvzdts_Z4vbqMmR065zd43bhYoMs7POSc4lufyt8AZmFdOwwqBlqxTrvt8cfqumfSxU3AV_qb_qHb7a-7ny1O6Z-RA-kFWpzOrz6d5X0lhdxyKjZ5SbTmDsItayQ3VBs5ZX4aguGBgcdoprSaasG0DNyX0qVqVuBZaOYKqyFApC_RQd3U_jXCwTlTuUp7MF4mrZUyOEmsYB6AnnifITJMrLI9zXisdnGtUrghheqEoUAYKglDkQx93N1z05Fs_LX3SZTXrmckyE5_gNqoXm3Uv9QmQx-itFU0Yxie1f1pBHjJSIilZrJg8Di4Zuho1BPMz46a3w36omJTzFmrfbNtFSXgCnMIt8sMver0ZzdmWklKJYcWOdKs0UuNW-rV18T-TSCGZBUrDv_HNLxBj4pkFQSWyyN0sLnd-rfgZW3MBN0vl-UEPTiZX3y5nCTzguuimP0G6fAmBg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosome+miR-199a-5p+modulated+vascular+remodeling+and+inflammatory+infiltration+of+Takayasu%E2%80%99s+arteritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Shuning+Guo&rft.au=Jiehan+Li&rft.au=Shurui+Pang&rft.au=Jing+Li&rft.date=2025-01-20&rft.pub=BMC&rft.eissn=1478-6362&rft.volume=27&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs13075-025-03475-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e17535215b20449684648ac69e306ef4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon